Find News

Filter articles

Showing 3251 to 3260 of 3709 results

Shire agrees NPS Pharma buyout

UK12-01-2015Mergers & acquisitions

Biopharmaceutical company Shire has agreed a multi-billion pound deal to buy US business NPS Pharmaceuticals, which operates in the same industry.

Glenmark Pharma celebrates as Abbott patent revoked


Glenmark Pharmaceuticals has been handed victory after the Indian Patent Office reversed a ruling that had granted a patent to US company Abbott Biotechnology for its anti-arthritis drug Humira (adalimumab).

Teva and Mylan get green light to launch Novartis generics


Pharmaceutical companies Teva and Mylan have each been granted permission to market a generic version of Novartis’s blood pressure treatment Diovan (valsartan) in the US.

UK man charged over fake erectile dysfunction pills


Police in the UK have charged a man after accusing him of selling counterfeit drugs including erectile dysfunction and abortion medicines online.

FDA gives nod to Novartis cancer biosimilar


The US Food and Drug Administration has recommended that an application by pharmaceutical company Novartis to market a biosimilar version of Amgen’s cancer drug Neupogen (filgrastim) be approved.

Ibuprofen agreement signed with mystery healthcare company


US pharmaceutical company Strategic Science and Technologies has signed an option agreement with “one of the world’s largest over-the-counter healthcare companies” to commercialise one of its ibuprofen products.

Fitzpatrick Cella promotes three litigators to partner


Law firm Fitzpatrick, Cella, Harper, & Scinto will begin the New Year with three new faces in its partnership.

December newsletter in 60 seconds


The battle between innovative pharma companies and generic drug rivals is a constant source of interest.

International Stem Cell Corporation welcomes CJEU embryo ruling

EU19-12-2014Legal developments

A US biotechnology company that was on the winning side of an EU court ruling surrounding the patentability of certain organisms has said it “clears the way” for patents in Europe.

French pharma company moves its IP to Ireland

France, Ireland18-12-2014

France-based pharmaceutical company Flamel Technologies has moved its IP to Ireland.

Showing 3251 to 3260 of 3709 results